Tfo Tdc, LLC Eli Lilly & CO Transaction History

Tfo Tdc, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $2.74 Million - $3.67 Million	-4,626 Reduced 99.83%	8 $6,000
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $2.43 Million - $2.86 Million	4,625 Added 51388.89%	4,634 $2.7 Million
Q3 2023 Nov 02, 2023	BUY	$434.7 - $599.3 $434 - $599	1 Added 12.5%	9 $4,000
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $104,871 - $140,225	-299 Reduced 97.39%	8 $3,000
Q1 2023 May 03, 2023	BUY	$310.63 - $364.82 $88,529 - $103,973	285 Added 1295.45%	307 $105,000
Q4 2022 Feb 03, 2023	BUY	$321.55 - $374.67 $7,074 - $8,242	22 New	22 $8,000
Q2 2022 Jul 18, 2022	BUY	$278.73 - $327.27 $14,215 - $16,690	51 New	51 $17,000

3,887

763M

6.34M

7.97M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Tfo Tdc, LLC, based on Form 13F filings with the SEC.

Stay updated on Tfo Tdc, LLC with notifications on news.